Top of this page
Skip navigation, go straight to the content
UCB is seeking to expand its pipeline and product portfolio with innovative products that will treat patients suffering from severe diseases. Our main areas of interest include: central nervous system (CNS) disorders and immunology diseases.
epilepsy
movement disorders
neurodegenerative disorders
neuromuscular diseases
multiple sclerosis (MS)
neuropathic pain
Rheumatoid arthritis (RA)
Crohn's disease (CD)
ulcerative colitis (UC)
systematic lupus erythematosus (SLE)
osteoporosis/bone diseases